MARKET

XLO

XLO

Xilio Therapeutics, Inc.
NASDAQ
8.63
+0.39
+4.74%
Opening 11:33 03/31 EDT
OPEN
8.33
PREV CLOSE
8.24
HIGH
8.81
LOW
8.33
VOLUME
18.55K
TURNOVER
--
52 WEEK HIGH
16.52
52 WEEK LOW
6.47
MARKET CAP
49.87M
P/E (TTM)
-2.0578
1D
5D
1M
3M
1Y
5Y
1D
Insider Move at Xilio Therapeutics Sparks Fresh Investor Interest
TipRanks · 13h ago
Xilio director Shannon James Samuel buys USD 0.04 million common shares
Reuters · 18h ago
Weekly Report: what happened at XLO last week (0323-0327)?
Weekly Report · 1d ago
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
NASDAQ · 5d ago
XILIO THERAPEUTICS INC <XLO.O>: LEERINK PARTNERS ADJUSTS TARGET PRICE TO $20 FROM $2 TO REFLECT 1-FOR-14 REVERSE STOCK SPLIT
Reuters · 03/24 12:28
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco
Reuters · 03/24 07:39
BUZZ-U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla
Reuters · 03/23 15:58
BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker
Reuters · 03/23 13:08
More
About XLO
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. It is using its proprietary platform to build a pipeline of novel, tumor-activated I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines, antibodies, bispecific and immune cell engagers. Its pipeline products include Vilastobart (XTX101), XTX301, XTX501, and tumor-activated bispecific molecules and immune cell-engaging molecules. XTX101 is an investigational tumor-activated, Fc-enhanced, high-affinity binding anti-CTLA-4 monoclonal antibody. XTX301, a tumor-activated, engineered interleukin 12, or IL-12, therapy.

Webull offers Xilio Therapeutics Inc stock information, including NASDAQ: XLO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XLO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XLO stock methods without spending real money on the virtual paper trading platform.